We develop and provide a comprehensive portfolio of prescription pharmaceuticals and evidence-based nutraceuticals focused on neurosciences, psychiatry, paediatrics, orthopaedics, general medicine, and pain management, addressing diverse therapeutic needs to enhance patient care globally.
“At Amygdala Pharmaceutical, we advance global health through innovative, accessible medicines. Our advanced formulations address complex needs across digestive care, neuropathic pain, brain health, nutrition, and bone support. Every product is research-driven and designed for real-world effectiveness, empowering healthcare professionals and improving patient outcomes worldwide.”
18+ years of CNS research expertise
A passionate workforce committed to quality, compliance, and exceptional service in the pharmaceutical sector.
Strategically scaling operations with an aim to reach national and international markets in the coming years.
Built on a strong operational foundation, the company continues to move forward with consistent and responsible financial progress.
Guiding principles that define who we are and how we operate
At Amygdala Pharmaceutical Pvt. Ltd., patient well-being is at the core of every decision we make. We are committed to delivering safe, effective, and reliable pharmaceutical solutions that improve health outcomes and enhance quality of life. Our approach focuses on understanding patient needs, ensuring product accessibility, and maintaining the highest standards of care throughout our operations.
Scientific excellence is a driving force behind every product and process at Amygdala Pharmaceutical Pvt. Ltd. We are committed to applying evidence-based practices, advanced research insights, and rigorous scientific methods to ensure the highest quality in our formulations. Our focus on continuous improvement, accuracy, and technological advancement enables us to meet evolving healthcare needs with precision and reliability.
Integrity and ethics form the foundation of Amygdala Pharmaceutical Pvt. Ltd. We are committed to conducting all our operations with transparency, honesty, and accountability. Our decisions and actions are guided by strict ethical standards, regulatory compliance, and a deep sense of responsibility toward patients, partners, and the healthcare ecosystem. By upholding these principles, we build trust and long-term credibility in everything we do.
Our experienced leadership team brings together decades of pharmaceutical expertise, scientific innovation, and strategic vision to advance our mission of improving lives through neuroscience.
Our diverse portfolio includes pharmaceutical products addressing critical therapeutic areas across CNS disorders, cardiovascular health, oncology, and metabolic diseases.
Prazodoc-DSR Capsules are a dual-action pharmaceutical formulation designed for effective control of gastric acidity and enhanced digestive comfort. T...
Norpega-NT Tablets are a pharmaceutical multimodal formulation designed for effective management of peripheral neuropathic pain. The dual-action combi...
Gabrionix ER-300 Tablets are a pharmaceutical formulation featuring a revolutionary gastro-retentive extended-release system that provides up to 24-ho...
Bevrixa-50 Tablets are a pharmaceutical antiepileptic formulation designed for advanced control of partial-onset seizures. Containing brivaracetam, th...
Valproxa ER-500 Tablets are an extended-release pharmaceutical formulation of divalproex sodium, designed for effective seizure control and mood stabi...
Cerecura-P Tablets are a pharmaceutical cognitive support formulation designed to enhance memory, learning, and overall brain performance. The combina...
Cartuff-II Tablets are a pharmaceutical formulation indicated for the management of osteoarthritis and various forms of arthritis. The formulation tar...
Myrafast Forte Tablets are a pharmaceutical formulation designed for multimodal pain relief, because every move matters. The formulation combines adva...
Kalmona-D3 Tablets are a pharmaceutical bone-health formulation designed to promote strong bones and a steady, active life. The formulation combines C...
Maximeg-3 Syrup is a pharmaceutical formulation designed to support strength, mental clarity, and healthy aging. It combines Omega-3 fatty acids (EPA ...
Carnodale Syrup is a pharmaceutical neuroprotective formulation designed to support critical brain development pathways, particularly the amygdala. It...
Carnodale Plus Syrup is a pharmaceutical neurodevelopment support formulation specially designed for children aged 2 to 14 years. It combines L-Carnos...
Q-ZAC Soft Gel Capsules are a pharmaceutical formulation designed to nourish the brain and support neurodevelopmental functions, with a focus on the a...
Our diverse portfolio of pharmaceutical products spans multiple therapeutic categories, addressing critical healthcare needs worldwide. Each product undergoes rigorous quality control and meets global regulatory standards.
13 Active Products
Research & Development (R&D) involves systematic work to expand knowledge and create new technologies, products, or processes. It drives innovation, competitiveness, and long-term economic growth, with data based on verified sources like OECD and UNESCO.
Research & Development encompasses systematic and creative efforts designed to increase the stock of human knowledge and use that knowledge to devise new applications. According to recognised international methodology, an activity qualifies as R&D only if it is novel, creative, uncertain in outcome, systematic, and potentially reproducible.
R&D typically includes:
Basic research: Exploration of fundamental principles without immediate commercial application.
Applied research: Targeted investigation geared toward specific objectives.
Experimental development: Using existing knowledge to create or improve products and processes
.
Amygdala Pharmaceutical Pvt. Ltd. is committed to delivering products that meet the highest levels of safety, purity, and effectiveness. Our manufacturing processes follow strict regulatory guidelines to ensure every formulation reflects our promise of quality and reliability.
Amygdala Pharmaceutical Pvt. Ltd. collaborates with a network of certified manufacturing units equipped with advanced production technology and robust quality systems. These facilities follow national and international standards, enabling us to deliver dependable pharmaceutical products across diverse therapeutic categories.
Our manufacturing network is selected through strict assessment of compliance, technical capability, and quality output. By partnering with GMP-approved units, we guarantee timely production, reliable supply, and consistent adherence to regulatory requirements throughout every stage of the manufacturing cycle.
From development to delivery, we ensure every product meets uncompromised safety and performance standards.
We serve patients in 1+ countries worldwide through our global commercial operations, with regional headquarters managing key markets.
Amygdala Pharmaceuticals operates through 4 regional hubs that manage commercial activities across their respective territories. Our global footprint allows us to serve diverse patient populations while maintaining local expertise.
We have established commercial operations in North America, Europe, Asia-Pacific, and key emerging markets. Our products are available in 1+ countries, with ongoing expansion into additional territories.
1+ countries served
CERECURA-P Tablets combine Citicoline and Piracetam to support memory, focus, attention, and overall...
Read More
BEVRIXA-50 (Brivaracetam 50 mg) offers rapid and effective control of partial-onset seizures with im...
Read More
VALPROXA ER-500 (Divalproex Sodium ER) provides long-acting control of seizures with added mood-stab...
Read MoreJoin our team of dedicated professionals working to advance neuroscience and improve patient lives worldwide.
At Amygdala Pharmaceuticals, we offer a dynamic and collaborative work environment where innovation thrives. Our employees are at the heart of everything we do.
We provide competitive compensation, comprehensive benefits, professional development opportunities, and a culture that values diversity, inclusion, and work-life balance.
📍 Location:
Asansol
📋 Type:
Full time
💰 Salary:
20,000/- to 30,000/-
⏰ Deadline:
Feb 28, 2026
We welcome inquiries from healthcare professionals, patients, investors, media, and other stakeholders.
Brij Residency, G T Road, Ground Floor, Shop No. A/3, Barabani, Bardhaman, West Bengal, 713304, India.
+91 9732155540
Monday - Friday, 8:00 AM - 6:00 PM IST
General: care@amygdalapharmaceutical.com
Medical: care@amygdalapharmaceutical.com
Investors: care@amygdalapharmaceutical.com
Healthcare professionals: +91 9732155540
Patients: +91 9732155540
Pharmacovigilance: care@amygdalapharmaceutical.com